Back to Journals » Drug Design, Development and Therapy » Volume 16

Induction of Apoptosis and Autophagy via sirtuin1- and PI3K/Akt/mTOR-Mediated Pathways by Plumbagin in Human Prostate Cancer Cells [Retraction]

Authors Zhou Z, Li X, He Z, Pan S, Yang Y, Zhang X, Chow K, Yang T, Qiu J, Zhou Q, Tan J, Wang D, Zhou S

Received 26 July 2022

Accepted for publication 26 July 2022

Published 29 July 2022 Volume 2022:16 Pages 2437—2438

DOI https://doi.org/10.2147/DDDT.S383775



Zhou Z, Li X, He Z, et al. Drug Des Devel Ther. 2015;9:1511–1554.

The Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of western blot bands in Figure 5 with those from an unrelated article. Specifically,

In addition, further analysis found that western blot bands in Figures 8 and 9 also appeared to be duplicated. Specifically,

  • Figure 8A, β-actin, PC-3 cells, appears to have been duplicated with a similar image from Figure 9A, β-actin, PC-3 cells.
  • Figure 8A, β-actin, DU145 cells, appears to have been duplicated with a similar image from Figure 9A, β-actin, DU145 cells.

The authors responded to our queries but were unable to provide a satisfactory explanation for the duplicated images, nor were they able to provide any original data for their study. The decision was made to retract the article and the authors were notified of this.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.